CorMedix (CRMD) had the highest return in Q1 2015 by a US stock with a market cap of $300M to $10B, returning 409.8%.
| ASSET | QUARTER | % RETURN |
|---|---|---|
CorMedix (CRMD) | Q1 2015 | 409.84% |
Soleno Therapeutics (SLNO) | Q1 2015 | 344.44% |
Celsius (CELH) | Q1 2015 | 149.97% |
Quantum Computing (QUBT) | Q1 2015 | 141.67% |
Capricor Therapeutics (CAPR) | Q1 2015 | 129.87% |
Esperion Therapeutics (ESPR) | Q1 2015 | 123.13% |
Frp Holdings Ord (FRPH) | Q1 2015 | 121.43% |
Microvision (MVIS) | Q1 2015 | 94.89% |
Travere Therapeutics (TVTX) | Q1 2015 | 94.32% |
Corcept Therapeutics (CORT) | Q1 2015 | 86.05% |
Prothena (PRTA) | Q1 2015 | 81.62% |
Ocular Therapeutix (OCUL) | Q1 2015 | 78.58% |
Codexis (CDXS) | Q1 2015 | 78.13% |
Pampa Energia SA ADR (PAM) | Q1 2015 | 75.47% |
Exelixis (EXEL) | Q1 2015 | 74.83% |
Empresa Distribuidora y Comercializadora Norte SA ADR (EDN) | Q1 2015 | 70.64% |
Applied Digital (APLD) | Q1 2015 | 70.1% |
Cantaloupe (CTLP) | Q1 2015 | 69.75% |
Universal Display (OLED) | Q1 2015 | 67.14% |
Semler Scientific (SMLR) | Q1 2015 | 65.88% |
Precigen (PGEN) | Q1 2015 | 63.26% |
Uniqure (QURE) | Q1 2015 | 62.13% |
Cryoport (CYRX) | Q1 2015 | 61.8% |
Wayfair (W) | Q1 2015 | 60.68% |
Rigel Pharmaceuticals (RIGL) | Q1 2015 | 58.67% |
